Streetbeat News

Price Targets

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:24 pm

MRT

Cantor Fitzgerald analyst Brett Knoblauch has initiated coverage on Marti Techs (AMEX:MRT) with an Overweight rating and set a price target of $0.9.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:21 pm

HTLF

Keefe, Bruyette & Woods analyst Damon Delmonte has maintained a 'Market Perform' rating on Heartland Financial USA (NASDAQ:HTLF) and increased the price target from $34 to $35.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:20 pm

BUSE

Keefe, Bruyette & Woods analyst Damon Delmonte has maintained an Outperform rating on First Busey (NASDAQ:BUSE) and increased the price target from $24 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:17 pm

SWTX

Goldman Sachs analyst Corinne Jenkins has reaffirmed a Buy rating on SpringWorks Therapeutics (NASDAQ:SWTX) and increased the price target from $47 to $52.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:12 pm

CRNC

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Cerence Inc. (NASDAQ:CRNC) and reduced the price target from $28 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:10 pm

SKIL

B. Riley Securities analyst Raj Sharma has maintained a Buy rating on Skillsoft (NYSE:SKIL) but has reduced the price target from $80 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:07 pm

CRWD

CrowdStrike Holdings Inc (NASDAQ:CRWD) shares rose after reporting Q3 results that exceeded expectations with a 35% year-over-year revenue increase to $786 million, surpassing estimates. Earnings were at 82 cents per share, beating the 74 cents estimate. The company achieved a record $223 million in new ARR, ending the quarter with over $3 billion in ARR. Guidance for Q4 revenue is between $836.6 million to $840 million, and full-year revenue is expected to be $3.047 billion to $3.05 billion, both in line with estimates. Earnings guidance for Q4 is 81 to 82 cents per share, and full-year earnings are projected at $2.95 to $2.96 per share, above estimates. Several analysts raised their price targets for CRWD following the earnings report.

Portfolio Pulse from Adam Eckert

November 29, 2023 | 2:07 pm

BNS

BMO Capital analyst Sohrab Movahedi has maintained a Market Perform rating on Bank of Nova Scotia, while reducing the price target from C$73 to C$68.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:06 pm